Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number..
Redstoneconnect PLC (LON:REDS) Chief Executive Officer Mark Braund caught up with DirectorsTalk for an exclusive interview to discuss their £5.5 million contract win, their latest trading..
Gateley (Holdings) Plc (LON:GTLY) is a broad-based UK legal services firm. It floated on AIM in mid-2015. It is a leader in the UK mid market,..
1pm plc (LON:OPM) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview Q1: Mark,..
Gateley Holdings PLC (LON:GTLY) is a broad-based UK legal services firm. It floated on AIM in mid-2015. It is a leader in the UK mid market,..
Xafinity Plc (LON:XAF) is the topic of conversation when Zeus Capital’s Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview Q1: The..
Marshall Motor Holdings plc, (LON:MMH) one of the UK’s leading automotive retail groups, announced today the proposed strategic disposal (“Disposal”) of its wholly-owned leasing segment, Marshall..
Collagen Solutions plc (LON:COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announced today that..
Deltex Medical Group plc (LON:DEMG), the global leader in oesophageal Doppler monitoring (“ODM”) today announced the release and first sales of its new High Definition Impedance..
Savannah Resources Plc (LON:SAV) CEO David Archer talks to DirectorsTalk about the current level of interest in Lithium, what David likes about the Mina do Barroso..
After enjoying a flood of investment in July, the level of new funds finding their way into AIM’s Oil & Gas Exploration & Production sector slowed..
Safestyle UK Plc (LON:SFE) has released interim results for the six months ended 30 June. Revenue of £82.5m is +1.4% YoY (HY16 restated: £81.4m) however an..
Cambridge Cognition Holdings plc, (LON:COG), The neuroscience digital health company which develops and markets software products to improve brain health, announced today its unaudited Interim Results..
ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, has today provided the following update of its pivotal 52-week, randomised, double-blinded, Phase III clinical trial..
